print ISSN: 2411-3956
Azərbaycanca Русский
Different effects of myoinositol on ovarian reserve in patients with low ovarian reserve and polycystic ovary syndrome
##common.pageHeaderLogo.altText## Actual Questions of Modern Gynecology and Perinatology
Vol. 9 No. 4 (2022)
Original article

Different effects of myoinositol on ovarian reserve in patients with low ovarian reserve and polycystic ovary syndrome

Published: February 1, 2023
DOI: https://doi.org/10.28942/mgpam.v9i4.86

Abstract

In the article, the positive effect of myoinositol and its precursors on the ovarian reserve, fertiliza-tion frequency, stimulation duration and reducing the amount of medication, live birth frequency in patients with low ovarian reserve and polycystic ovary syndrome was investigated based on literature data. Additional studies are needed to investigate the dosage, duration of administration, selection accor-ding to different groups, and effectiveness.

References

Francesca Caprio, corresponding author Maria Diletta D’Eufemia, Carlo Trotta, Maria Rosaria Campitiello, Raffaele Ianniello, Daniela Mele, and Nicola Colacurci. J Ovarian Res. 2015; 8: 37.

Published online 2015 Jun 12. doi: 10.1186/s13048-015-0167-x PMCID: PMC4464995 PMID: 26067283

Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial.

Sahar Mohammadi, Fatemeh Eini, Fatemeh Bazarganipour,2 Seyed Abdolvahab Taghavi, and Maryam Azizi Kutenaeecorresponding author. Reprod Biol Endocrinol. 2021; 19: 61. Published online 2021 Apr 23. doi:10.1186/s12958-021-00741-0 PMCID: PMC8063404 PMID: 33892722. The

effect of Myo-inositol on fertility rates in poor ovarian responder in women undergoing assisted reproductive technique: a randomized clinical trial

Myo-inositol for the Management of Poor Ovarian Responders: A Prospective Randomized Controlled Trial First Posted : February 18, 2020 Last Update Posted: February 18, 2020

Gateva A, Unfer V, Kamenov Z. The use of inositol (s) isomers in the management of polycystic ovary syndrome: a comprehensive review. Gynecol Endocrinol. 2018;34(7):545–550. doi:

1080/09513590.2017.1421632. [PubMed] [CrossRef] [Google Scholar]

Myo-inositol for the Management of Poor Ovarian Responders: A Prospective Randomized Controlled Trial. American University of Beirut Medical Center 27 February 2022.

Priya Bhide, Jyotsna Pundir, Anil Gudi, Amit Shah, Roy Homburg, Ganesh Acharya. The effect of myo-inositol/di-chiro-inositol on markers of ovarian reserve in women with PCOS undergoing IVF/ICSI: A systematic review and meta-analysis. First published: 16 April 2019.

Leila Nazaria Saghar Salehpourb Sedigheh Hosseinib Nasrin Saharkhizb Elham Azizic Teibeh

Hashemiab Robabeh Ghodssi-Ghassemabadid. Effect of myo-inositol supplementation on ICSI

outcomes among poor ovarian responder patients: A randomized controlled trial may 2020.

Chiu TT, Tam PP. A correlation of the outcome of clinical in vitro fertilization with the inositol

content and embryotrophic properties of human serum. J Assist Reprod Genet. 1992;9(6):524–530.

doi: 10.1007/BF01204248. [PubMed] [CrossRef] [Google Scholar]

P-A Regidor, AE Schindler, B Lesoine, R Druckman. Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature. Hormone molecular biology and clinical investigation, 2018 | added to CENTRAL: 30 April 2018 | 2018 Issue 4.

Papaleo E, Unfer V, Baillargeon JP, Fusi F, Occhi F, De Santis L. Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.

Fertil Steril. 2009;91(5):1750-1754. doi: 10.1016/j.fertnstert.2008.01.088. [PubMed] [CrossRef] [Google Scholar]

Nestler J.E., Jakubowicz D.J., Reamer P., Gunn R.D., Allan G. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N Engl J Med. 1999;340(17):1314–1320. doi: 10.1056/NEJM199904293401703. [PubMed] [CrossRef] [Google Scholar]

Who is myo-inositol for? And who should stay away from it? February 2020 issue of CHR VOICE Norbert Gleicher, MD, FACOG, FACS leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology.

Myo-inositol Fertility Benefits: Does myo-inositol improve egg quality and IVF success rates? This is a part of the March 2019 CHR VOICE. Norbert Gleicher, MD, FACOG, FACS leads CHR’s clinical

and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology.

P. Rizzo, E. Raffone, V. Benedetto. Eur Rev Med Pharmacol Sci 2010; 14 (6): 555-561 Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective,

clinical trial. Department of Obstetrics and Gynecology, University of Messina, Messina (Italy).

Zheng, Xiangqin MD; Lin, Danmei MD; Zhang, Yulong MD; Lin, Yuan MD; Song, Jianrong MD; Li, Suyu MD; Sun, Yan MD Editor(s): Inositol supplement improves clinical pregnancy rate in

Müasir ginekologiya və perinatologiyanın aktual məsələləri 09 №03/2022

infertile women undergoing ovulation induction for ICSI or IVF-ET. Wane., Daryle Medicine 96(49):p e8842, December 2017.

Front. Pharmacol., 11 October 2019 Sec. Experimental Pharmacology and Drug Discovery https://doi.org/10.3389/fphar.2019.01172 Myo-Inositol and Its Derivatives: Their Emerging Role in the Treatment of Human Diseases Dhani Raj Chhetri.

Health Guide / Fertility Last updated: Aug 20, 2021 What we know so far about myo-inositol for fertility Medically Reviewed by Eduardo Hariton, MD, MBA Written by Talia Shirazi, PhD.

Unfer V, Carlomagno G, Dante G, Facchinetti F. Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecol Endocrinol. 2012;28(7):509–515. doi: 10.3109/09513590.2011.650660. [PubMed] [CrossRef] [Google Scholar].

S. Mohammadi, F. Eini, F. Bazarganipour, S.A. Taghavi, M.A. Kutenaee. The effect of Myo-inositol on fertility rates in poor ovarian responder in women undergoing assisted reproductive technique: a randomized clinical trial. Reproductive biology and endocrinology : RB&E, 2021, 19(1), 61 | added to CENTRAL: 30 June 2021 | 2021 Issue 06.

PDF (Azərbaycanca)
PDF (Azərbaycanca)

Keywords

AFC-antral follicle count
AMH-antimüllerian hormone
MI-myoinositol
DMI-D-myoinositol
OSI-ovarian sensitivity index PCO-polikistik yumurtalıq sindromu
AFC-antral follikulların sayı
AMH-antimüllerian hormon
MI-mioinositol
DMI-D-mioinositol
OSI-yumurtalıqların həssaslıq indeksi СПКЯ-синдром поликистозных яичников
КАФ-количество антральных фолликулов
AMГ-антимюллеров гормон
MИ-миоинозитол
гормон, MИ-миоинозитол, ДMИ-Д-миоинозитол, ИЧЯ-индекс чувствительности яичников

Most read articles by the same author(s)

<< < 1 2 3 > >>